Discover 480 paid clinical trials in Conway, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 480
FeaturedActive & Responsive
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
for
Muscular Atrophy, Spinal
Location: Little Rock AR, Dallas TX, Atlanta GA, Grand Rapids MI,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 2
Code: NCT05861999
Recruiting
FeaturedActive & Responsive
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
for
Juvenile Psoriatic Arthritis
Location: Little Rock AR, Austin TX, Indianapolis IN,
Sponsor: AbbVie
Sex: All
Age: 5 - 17
Code: NCT06100744
Phase 3, Recruiting
Featured
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Little Rock AR, Ridgeland MS, Waxahachie TX,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase 3, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Little Rock AR, Glenwood AR, Hot Springs AR,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Featured
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
for
Episodic Migraine
Location: Little Rock AR, Ridgeland MS, Waxahachie TX,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05711394
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Little Rock AR, Richardson TX, Austin TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07145918
Phase 2, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Location: Little Rock AR, North Little Rock AR, Cordova TN,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06419374
Phase 3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Little Rock AR, St Louis MO, Arlington TX, Mansfield TX,
Sponsor: AbbVie
Sex: All
Age: 2 - 11
Code: NCT06461897
Phase 3, Recruiting
Featured
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
for
Muscular Atrophy, Spinal
Location: Little Rock AR, Dallas TX, Fort Worth TX, Atlanta GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 2
Code: NCT05861986
Recruiting
Featured
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, c-MET
Location: Little Rock AR, Tyler TX, Dallas TX, Nashville TN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06568939
Phase 2, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Location: North Little Rock AR, Cordova TN, West Monroe LA,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06318169
Phase 3, Recruiting
Active & Responsive
Prenatal Exercise and Glucose Regulation
for
Gestational Diabetes Mellitus,
Location: Conway AR
Sponsor: University of Central Arkansas
Sex: Female
Age: 18 - 35
Code: NCT07802262
Recruiting
Active & Responsive
Caris Biorepository Research Protocol
for
Cancer, Early Detection of Cancer, Minimal Residual Disease
Location: Little Rock AR, Jonesboro AR, Texarkana TX,
Sponsor: Caris Science, Inc.
Sex: All
Age: 18+
Code: NCT01499394
Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Little Rock AR, Jackson MS, Jefferson City MO,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Little Rock AR, Saint Charles MO, Plano TX,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07489651
Phase 2, Recruiting
Active & Responsive
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
for
Post Traumatic Stress Disorder
Location: Little Rock AR, Memphis TN, Saint Charles MO,
Sponsor: Transcend Therapeutics
Sex: All
Age: 18+
Code: NCT07456696
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: Little Rock AR, Rogers AR, Saint Charles MO, Plano TX,
Sponsor: atai Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06524830
Phase 2, Recruiting
Active & Responsive
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for
Major Depressive Disorder
Location: Little Rock AR, St Louis MO, Atlanta GA, Austin TX,
Sponsor: Definium Therapeutics US, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07592689
Phase 3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Little Rock AR, Saint Charles MO, Richardson TX,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06830044
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
for
Bipolar Disorder Type I With Mania
Location: Little Rock AR, Rogers AR, Bentonville AR, Flowood MS,